Suncoast Clinical Research is conducting a research study for adults who may be at higher risk for heart-related events due to elevated levels of lipoprotein(a), also known as Lp(a). This study is exploring whether an investigational medication may help lower cardiovascular risk before a first major heart event occurs, such as a heart attack or the need for urgent heart procedures.
Cardiovascular Prevention Research Study
Age Range:
50
Gender:
Male and Female
Location:
New Port Richey
About the Study
Lp(a) is a type of cholesterol that is largely determined by genetics and cannot be reliably lowered with diet, exercise, or most available medications. People with high Lp(a) may have a higher risk of developing heart disease—even if they haven’t had a heart attack or stroke before.
This study is evaluating an investigational medication which is designed to reduce Lp(a) levels in the body. Researchers want to learn whether lowering Lp(a) may help prevent first-time major cardiovascular events in people who are considered at risk.
Qualifications
You May qualify if you:
- Are 50 years of age or older
- Have elevated Lp(a) levels (confirmed through study screening)
- Have risk factors for heart disease or evidence of plaque buildup in the arteries
- Have not had a previous major cardiovascular event (such as a heart attack or stroke)